Reading this on a mobile device? Try our optimized mobile version here:

November 15, 2012News for medical technology professionals

  Top Story 
  • Medtech leaders: Device tax hurts innovation
    The U.S. occupies 40% of the global medtech market, creating a $5.4 billion trade surplus, but that could change if the 2.3% medical device tax is allowed to take effect next year, write Dan Moore of Cyberonics, Greg Sorensen of Siemens Healthcare North America and Timothy M. Ring of C. R. Bard in this article. "Put simply, this is a tax on innovation, and it is going to hurt American workers and patients most," they write. The tax is already having an effect, as companies are canceling growth plans and trimming R&D budgets in anticipation. Politico (Washington, D.C.) (11/14) LinkedInFacebookTwitterEmail this Story
Streamline Combination Product Development
This complimentary white paper from Novella Clinical explores combination product regulatory strategies - from classification to market clearance. Combination product sponsors can avoid numerous regulatory hurdles by downloading this white paper now: Clarifying the Regulatory Road for Combination Products.
  Business & Market Trends 
  • Nihon Kohden announces deal to acquire Defibtech
    Nihon Kohden has agreed to acquire Defibtech, a Guildford, Conn.-based maker of automatic external defibrillators, in a deal set to be finalized at the end of the month. The deal will allow the Tokyo device company to strengthen its foothold in the U.S. resuscitation technology market. The Hartford Courant (Conn.) (11/13) LinkedInFacebookTwitterEmail this Story
  • Funding round pulls in $10 million for Hansen Medical
    A regulatory filing disclosed that Hansen Medical has obtained $10 million in a funding round. The Mountain View, Calif.-based company develops flexible robotics technology for clinical uses, including the Magellan Robotic System designed to aid doctors during intravascular procedures. (11/14) LinkedInFacebookTwitterEmail this Story
  • T2 secures 2 additional patents for rapid diagnostic device
    T2 Biosystems has secured two additional patents covering its T2MR diagnostic tool, which President and CEO John McDonough says can spot "anything" from certain DNA types to the blood's clotting ability in biological samples within a few hours. The company now has 16 global patents for the device, which will be tested for use in detecting Candida fungal blood infections. Mass High Tech (Boston) (11/14) LinkedInFacebookTwitterEmail this Story
Bluetooth® technology transforms medical devices
Discover new product possibilities. Leverage a proven, ubiquitous ecosystem of billions of Bluetooth enabled devices. Download the free market study overview containing excerpts from an ABI report on the growth potential of Bluetooth low energy technology in medical and wellness.
  International Developments 
  Industry Insight 

  Science & Health 
  • Self-healing material may find application in prosthetics
    Scientists at Stanford University created a material that can sense pressure and heal itself from cuts, burns and tears. The U.S. Air Force Office of Scientific Research, which provided partial funding for the project, hopes to use the material in prosthetics, where it could quickly heal exterior damage to artificial limbs. An article about the invention was published in the journal Nature Nanotechnology. ABC News/Science blog (11/12) LinkedInFacebookTwitterEmail this Story
  Emerging Technologies 

Interested in learning more about advertising with SmartBrief? Click here for detailed industry information and media kits. 

  Government & Regulatory 
  • Medtech leaders hit Capitol Hill to push for device tax repeal
    A group of 50 top industry executives will descend today on Capitol Hill to inform lawmakers about the 2.3% medical device tax's devastating effect on jobs and persuade them to repeal the levy during the lame duck session, AdvaMed's David Nexon said. "[T]this excise tax will raise our industry’s federal tax liability by an amount equal to a whopping 29 percent of our current income tax payments," Nexon said, referencing an AdvaMed report released Wednesday about the cost of the device tax. (11/14) LinkedInFacebookTwitterEmail this Story
  • For more: Read the AdvaMed press release about the Ernst & Young-prepared report on the cost of the medical device tax. LinkedInFacebookTwitterEmail this Story
  • Venture capital group sees 2.3% device tax a top repeal priority
    The National Venture Capital Association has cited the 2.3% medical device tax set to begin next year as a top priority for repeal after the recent election. The group said the Democratic Senate might want to debate the levy "in the context of overall tax reform," a vision shared by AdvaMed, which in February issued a set of principles for amending the nation's tax system. (Boston) (11/14) LinkedInFacebookTwitterEmail this Story
AdvaMed News 
  • Join the AdvaMed-MTLI LinkedIn group!
    Build close relationships with member companies, both small and large, and receive an intimate understanding of the key issues affecting innovation, access and the bottom line. Interact in discussions that leverage the leadership and expertise of the medical technology industry. This social group is full of key stakeholders, influencers and industry thought leaders as well as regulatory and policy experts from the FDA and CMS. Aside from practical learning opportunities, this LinkedIn group provides the premier opportunity to network with key players from virtually every aspect of the industry. Link to the AdvaMed MTLI LinkedIn group page. LinkedInFacebookTwitterEmail this Story
Learn more about AdvaMed ->About AdvaMed | Join | Courses | Events | Newsroom

Position TitleCompany NameLocation
Director of Quality CEA Medical Manufacturing Colorado Springs, CO
Manager, Grassroots and Member Engagement, Government Affairs AdvaMedWashington, DC
Associate Vice President, Global Strategy and Analysis (Asian Region) AdvaMedWashington, DC
Manager, Regulatory Affairs Sequenom, Inc.San Diego, CA
Clinical Education Manager, Vascular TherapiesCovidienMansfield, MA
Senior/Principal Mechanical EngineerChannel MedsystemsSan Francisco, CA
Director, Global Labeling - 001592Edwards LifesciencesIrvine, CA
Director, Valve Testing - Transcatheter Heart Valve - 001221Edwards LifesciencesIrvine, CA
Compliance Manager, Global DistributionCooperVision, Inc.Rochester, NY or Pleasanton, CA, NY
Packaging Engineer/Project LeaderEndologix, Inc.Irvine, CA
Associate Director, Regulatory AffairsAbbott LaboratoriesSanta Clara, CA
Senior Marketing Communications Manager - Cardiac Surgery Systems - 001558Edwards LifesciencesIrvine, CA
Sr. Manager R & D, Systems Integration EngineeringAbbott LaboratoriesSanta Ana, CA
Physician Training Program ManagerEndologix, Inc.Irvine, CA
Director Clinical Research - CapnographyCovidienBoulder, CO
Regulatory Affairs Associate DirectorAbbott LaboratoriesSanta Clara, CA
Field Service Engineer IRIS International, IncSacramento, CA
Quality EngineerIRIS International, IncChatsworth, CA
Medical and Clinical Laboratory TechnologistIRIS International, IncChatsworth, CA
Senior Mechanical EngineerIRIS International, IncChatsworth, CA
Clinical & Customer Care SpecialistIRIS International, IncLos Angeles, CA
Developmental Cell Biologist/BiochemistIRIS International, IncCarlsbad, CA
Principal Systems Engineer IRIS International, IncChatsworth, CA
Field Service Engineer IRIS International, IncProvidence, RI
Director Professional Medical Education CovidienBoulder, CO
Senior Director, QualityAmerican Medical SystemsMinneapolis, MN
Click here to view more job listings.

Keep your fears to yourself but share your courage with others."
--Robert Louis Stevenson,
Scottish novelist, poet and essayist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Account Director:  Meryl Harold (202) 407-7828
Job Board:  Jackie Basso (202) 407-7871
A powerful website for SmartBrief readers including:
 Recent AdvaMed SmartBrief Issues:   Lead Editor:  Lisa Gough
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information